Listed on GrantGunner. Last checked 9 Jul 2026.
About this grant
The National Natural Science Foundation of China (NSFC) and the Bill & Melinda Gates Foundation (GF) jointly fund Chinese researchers and their international partners to conduct collaborative research in the field of women's health innovation, focusing on the discovery and translational research of druggable targets for endometriosis, as well as the discovery and translational research of druggable targets for non-hormonal treatment of uterine fibroids and adenomyosis. The project funding period is 3 years (January 1, 2027 to December 31, 2029). The funding intensity for the Chinese side does not exceed 1.5 million yuan per project, and the funding intensity from the Gates Foundation does not exceed 200,000 US dollars per project.
Who can apply
Must hold senior professional technical position (or title), and should be currently leading or have led a National Natural Science Foundation of China project with a duration of three years or longer; Chinese applicants must submit applications to both the National Natural Science Foundation of China and the Bill & Melinda Gates Foundation; the number of domestic collaborative research institutions must not exceed two; and must have a solid foundation for collaboration with overseas partners.
More grants from National Natural Science Foundation of China